Deep Brain Stimulation for Chronic Pain
(EPR Pain Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores deep brain stimulation (DBS), a treatment using electrical signals to manage chronic pain. The goal is to assess the safety and effectiveness of DBS for individuals with severe, long-lasting pain persisting for over a year, unresponsive to medications or surgery. Participants will have DBS leads (tiny wires) placed in specific brain areas to evaluate their response to different sensations. Suitable candidates for this trial have intractable pain that hasn't improved with other treatments and can manage the required evaluations and tasks. As an unphased trial, this study offers the chance to contribute to groundbreaking research that could lead to new pain management solutions.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. However, since the trial is for patients whose pain is not responsive to medication, it might be possible to continue your current medications. Please consult with the trial coordinators for specific guidance.
What prior data suggests that deep brain stimulation is safe for treating chronic pain?
Research has shown that deep brain stimulation (DBS) has been safely used in many patients over the years, particularly for neurological issues when other treatments failed. For chronic pain, a small study confirmed that DBS is safe, whether used alone or with other brain stimulation methods. This study found that DBS is generally well-tolerated, with most participants experiencing no major issues.
While results vary with other types of brain stimulation, evidence suggests that DBS can be used safely. DBS has been around for a while and is frequently tested for safety in various conditions, making it a promising option for those considering it for chronic pain relief.12345Why are researchers excited about this trial?
Researchers are excited about Deep Brain Stimulation (DBS) for chronic pain because it offers a novel approach by directly targeting the brain's pain centers. Unlike traditional treatments like medications or physical therapy, which often focus on managing symptoms, DBS involves implanting electrodes in the brain to modulate neural activity, potentially providing more precise and effective relief. This technique could offer hope for individuals who haven't found success with existing methods, as it has the potential to alter the brain's pain processing in a way that other treatments cannot.
What evidence suggests that deep brain stimulation is effective for chronic pain?
Research has shown that deep brain stimulation (DBS), which participants in this trial will receive, may help treat chronic pain. In some studies, patients experienced lasting pain relief after receiving DBS implants. These studies suggest that DBS can effectively manage chronic pain symptoms. However, not everyone benefits; some patients did not achieve the pain relief they hoped for. Overall, DBS has proven effective for some individuals in reducing chronic pain when other treatments have failed.23567
Are You a Good Fit for This Trial?
This trial is for adults aged 22-75 with chronic pain lasting over a year, severe (VAS score >6/10), and not responsive to medication or surgery. They must be able to give informed consent, have no cognitive impairments or conditions that increase surgical risk, and be capable of completing study tasks without significant psychological distress.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Implantation of DBS leads within the sensory thalamus and periaqueductal gray, followed by electrophysiological recordings
Follow-up
Participants are monitored for long-term safety and effectiveness of DBS leads for chronic pain treatment
What Are the Treatments Tested in This Trial?
Interventions
- Deep Brain Stimulation (DBS)
Deep Brain Stimulation (DBS) is already approved in United States, European Union, Canada for the following indications:
- Advanced Parkinson's disease
- Medically refractory tremor
- Dystonia
- Obsessive-compulsive disorder
- Parkinson's disease
- Essential tremor
- Dystonia
- Psychiatric conditions
- Parkinson's disease
- Essential tremor
- Dystonia
Find a Clinic Near You
Who Is Running the Clinical Trial?
St. Joseph's Hospital and Medical Center, Phoenix
Lead Sponsor